CRBU
Price:
$2.21
Market Cap:
$199.70M
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, a...[Read more]
Industry
Biotechnology
IPO Date
2021-07-23
Stock Exchange
NASDAQ
Ticker
CRBU
According to Caribou Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -34.76%. This represents a change of 285.90% compared to the average of -9.01% of the last 4 quarters.
The mean historical ROE of Caribou Biosciences, Inc. over the last ten years is -49.12%. The current -34.76% ROE has changed -29.23% with respect to the historical average. Over the past ten years (40 quarters), CRBU's ROE was at its highest in in the December 2020 quarter at 62.73%. The ROE was at its lowest in in the March 2020 quarter at -20.09%.
Average
-49.12%
Median
-27.71%
Minimum
-313.96%
Maximum
146.38%
Discovering the peaks and valleys of Caribou Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 91.50%
Maximum Annual ROE = 146.38%
Minimum Annual Increase = -146.62%
Minimum Annual ROE = -313.96%
Year | ROE | Change |
---|---|---|
2023 | -27.71% | -16.15% |
2022 | -33.04% | 91.50% |
2021 | -17.26% | -111.79% |
2020 | 146.38% | -146.62% |
The current ROE of Caribou Biosciences, Inc. (CRBU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-26.00%
5-year avg
-49.12%
10-year avg
-49.12%
Caribou Biosciences, Inc.’s ROE is greater than Intellia Therapeutics, Inc. (-49.70%), greater than Editas Medicine, Inc. (-62.61%), greater than CRISPR Therapeutics AG (-13.85%), greater than Verve Therapeutics, Inc. (-35.20%), greater than Beam Therapeutics Inc. (-16.22%), greater than Fate Therapeutics, Inc. (-44.09%), greater than Prime Medicine, Inc. (-113.34%), greater than Sana Biotechnology, Inc. (-71.60%), greater than Adaptive Biotechnologies Corporation (-71.96%),
Company | ROE | Market cap |
---|---|---|
-49.70% | $1.50B | |
-62.61% | $240.01M | |
-13.85% | $4.32B | |
-35.20% | $501.82M | |
-16.22% | $1.89B | |
-44.09% | $276.72M | |
-113.34% | $483.72M | |
-71.60% | $814.23M | |
-71.96% | $783.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caribou Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Caribou Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Caribou Biosciences, Inc.'s ROE?
How is the ROE calculated for Caribou Biosciences, Inc. (CRBU)?
What is the highest ROE for Caribou Biosciences, Inc. (CRBU)?
What is the 3-year average ROE for Caribou Biosciences, Inc. (CRBU)?
What is the 5-year average ROE for Caribou Biosciences, Inc. (CRBU)?
How does the current ROE for Caribou Biosciences, Inc. (CRBU) compare to its historical average?